Heterocyclic compounds for the inhibition of PASK

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9193693
SERIAL NO

14499981

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BIOENERGENIX, LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Clare, Michael Skokie, US 96 925
McCall, John M Boca Grande, US 93 846
McKearn, John Saint Louis, US 21 126
Romero, Donna L Chesterfield, US 69 752

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 24, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00